[HTML][HTML] Inflammatory rheumatic disorders and bone

IEM Bultink, M Vis, IE van der Horst-Bruinsma… - Current rheumatology …, 2012 - Springer
Inflammatory joint diseases such as rheumatoid arthritis, as well as other rheumatic conditions,
such as systemic lupus erythematosus (SLE) and ankylosing spondylitis, comprise a …

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

GJ Wolbink, M Vis, W Lems, AE Voskuyl… - Arthritis & …, 2006 - Wiley Online Library
Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …

Can bone loss in rheumatoid arthritis be prevented?

M Vis, M Güler-Yüksel, WF Lems - Osteoporosis International, 2013 - Springer
Rheumatoid arthritis (RA) is a systemic inflammatory disease that can lead to local joint
deformations (bone erosions and joint space narrowing) and to extra-articular phenomena, …

[HTML][HTML] Animal models of bone loss in inflammatory arthritis: from cytokines in the bench to novel treatments for bone loss in the bedside—a comprehensive review

CH Alves, E Farrell, M Vis, EM Colin… - Clinical reviews in allergy …, 2016 - Springer
Throughout life, bone is continuously remodelled. Bone is formed by osteoblasts, from
mesenchymal origin, while osteoclasts induce bone resorption. This process is tightly regulated. …

Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.

M Vis, MT Nurmohamed, G Wolbink… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: Cardiovascular morbidity and mortality appear to be enhanced in rheumatoid
arthritis (RA), which might be due to an increased prevalence of cardiovascular risk factors …

[HTML][HTML] Sex-specific differences and how to handle them in early psoriatic arthritis

E Passia, M Vis, LC Coates, A Soni… - Arthritis Research & …, 2022 - Springer
Objectives The prevalence of psoriatic arthritis (PsA) is the same in men and women;
however, the latter experience a higher burden of disease and are affected more frequently by …

Influence of disease manifestations on health-related quality of life in early psoriatic arthritis

…, JJ Veris-van Dieren, JMW Hazes, M Vis - The Journal of …, 2018 - jrheum.org
Objective. Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses,
and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We aim …

Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care

…, AEAM Weel, M van der Ven, M Vis… - …, 2017 - academic.oup.com
Objective. To compare the screening performance of the Psoriasis Epidemiology Screening
Tool (PEST), Psoriatic Arthritis Screening and Evaluation (PASE) and Early Arthritis for …

Effect of intramuscular vs intra-articular glucocorticoid injection on pain among adults with knee osteoarthritis: The KIS randomized clinical trial

…, MF Mol, PK Bos, DMJ Dorleijn, M Vis… - JAMA Network …, 2022 - jamanetwork.com
Importance Intra-articular (IA) glucocorticoid injection is widely used in patients with knee
osteoarthritis (OA), but the safety of this technique is in question among physicians. …

[PDF][PDF] Burden of psoriatic arthritis according to different definitions of disease activity: comparing minimal disease activity and the disease activity index for psoriatic …

K Wervers, M Vis, I Tchetveriko… - Arthritis Care & …, 2018 - Wiley Online Library
Objective Treat‐to‐target strategies have improved outcomes in rheumatic diseases. In
psoriatic arthritis (PsA), the proposed targets are the multidimensional target minimal disease …